Archives
What COMET Shows About LNP Design
2026-11-05
A critical synthesis of how COMET learned formulation-wide patterns from a large lipid nanoparticle dataset, what its performance metrics establish, and why reporter expression should not be treated as a universal measure of delivery or as evidence for any particular nucleotide material.
What COMET Reveals About LNP Comparisons
2026-11-05
A transformer-based study shows that lipid nanoparticle performance depends on interacting components, composition, and formulation context rather than on a single universally superior ingredient. Its strongest evidence concerns ranking related formulations, while cross-cell, in vivo, and nucleotide-specific conclusions remain limited.
COMET and the Composite Logic of LNP Design
2026-11-04
A literature-focused analysis of how COMET models lipid nanoparticle composition, formulation context and cell-specific readouts, with emphasis on its reported performance, biological interpretation and limits of transferability.
COMET and the Context of LNP Performance
2026-11-04
A transformer-based model was developed to represent complete lipid nanoparticle formulations rather than isolated molecules. The study indicates that material identity, relative composition and formulation-wide context jointly shape delivery readouts, while transfer across cell types, payloads and in vivo settings remains context-dependent.
What LNP AI Comparisons Actually Show
2026-11-03
A critical reading of COMET shows strong ranking performance within a large, structured lipid nanoparticle dataset, but weaker transfer across cell types and important limits on mechanistic and material-specific interpretation.
What LNP Models Actually Predict
2026-11-03
A mechanistic analysis of how COMET represents lipid nanoparticle composition, what its performance statistics establish, and why assay context limits broader conclusions about RNA delivery materials.
Why a CSN2 Knock-In Raised Rabbit Milk Yield
2026-11-02
A 2025 study tested whether placing a reporter transgene at the rabbit CSN2 milk-protein locus could overcome the variable expression associated with conventional transgenesis. The resulting line produced 15–20 g/L tdTomato in milk from two homozygous females, an important proof of concept, although the result does not yet establish therapeutic-product quality, process performance, or generality across proteins and animals.
What LNP Models Actually Learn About RNA Delivery
2026-11-02
A transformer model of lipid nanoparticle formulations shows why RNA-delivery performance is an emergent property of lipid identity, composition and formulation context. Its results clarify what luciferase readouts can establish, while also defining the limits of transferring those findings to chemically modified nucleotide cargos such as 5-Methoxy-UTP.
Interpreting Comparative LNP Design Evidence
2026-11-01
A large benchmark shows that lipid nanoparticle performance depends on coordinated component identities, composition and formulation context, while a transformer model can rank candidates effectively within related chemical spaces. The evidence is strongest for cell-based ranking and weaker for cross-cell generalization, in vivo translation and claims about any specific cargo or nucleotide material.
What COMET Reveals About LNP Design
2026-10-31
A literature-focused analysis of COMET, a transformer-based model that learned to rank lipid nanoparticle performance from component identities, composition and formulation-level features. The study shows strong within-dataset prediction and promising cross-context validation, while also exposing important limits in cell-line transfer, causal interpretation and translation from reporter expression to therapeutic performance.
What COMET Shows About LNP Design
2026-10-30
A transformer-based model improved ranking of lipid nanoparticle performance, but the evidence supports context-specific formulation prediction—not direct conclusions about 5-Methoxy-UTP or universal in vivo efficacy.
PET Tracking of mRNA Antigen Expression
2026-10-30
A reporter-based PET strategy offers a way to visualize where and for how long an mRNA-encoded antigen is expressed in vivo. The highlighted preclinical work supports the method’s value for mapping antigen-expression dynamics, while leaving questions about reporter effects, quantitative calibration, and clinical relevance unresolved.
When Context Changes a Biological Result
2026-10-29
A result’s meaning depends on the model, comparator, perturbation, and measurement layer that produced it. The octanal–Olfr2–NHE1 study illustrates how convergent animal, cellular, genetic, and biochemical evidence can support a mechanistic model while still leaving important questions about specificity, assay interpretation, and translation.
COMET and the Logic of LNP Design
2026-10-29
A literature-focused analysis of how COMET models lipid nanoparticle efficacy across component identities, composition, formulation context and cell types, with emphasis on what the reported correlations establish—and where transferability remains limited.
5-Methoxy-UTP and the Limits of LNP Evidence
2026-10-28
A transformer-based model showed that lipid nanoparticle performance depends on interacting components, composition and formulation-wide features rather than on a single lipid. The evidence supports COMET as a ranking and hypothesis-generation framework for the specific messenger RNA delivery assays studied, but it does not establish a performance claim for 5-Methoxy-UTP itself.